Variants of SLC6A1, SLC2A1, and SCN1A are relatively common in patients with MAE, with reported variant rates of 4% (6/160),11 4.8% (4/84),9 and 5% (1/20),31 respectively. This evidence concerns the gene SLC2A1 and epilepsy with myoclonic atonic seizures.